Skip to content
Sign in
Artwork for Headline: HIV
Headline: HIV · August 3 · 1 min

Stem Cell & Tatelo-plus

This digest is brought to you by the podcast HIV: The Morning After. Two new cases of long-term HIV remission following a stem-cell transplant from a donor with a rare genetic resistance to HIV (CCR5-delta32) were presented, both with serious complications including a hepatitis B reactivation and incomplete engraftment with several infections, according to the International AIDS Society. In the small, ongoing Tatelo-plus paediatric study in Botswana, all infants remained undetectable at 24 weeks on broadly neutralising antibodies, though one researcher cautioned that antibodies plus lenacapavir amount to suppression rather than a cure, according to the International AIDS Society.

0:00-1:58
Play in

transcript

No transcript — this publisher did not publish one.

show notes

This digest is brought to you by the podcast HIV: The Morning After.

Two new cases of long-term HIV remission following a stem-cell transplant from a donor with a rare genetic resistance to HIV (CCR5-delta32) were presented, both with serious complications including a hepatitis B reactivation and incomplete engraftment with several infections, according to the International AIDS Society.

In the small, ongoing Tatelo-plus paediatric study in Botswana, all infants remained undetectable at 24 weeks on broadly neutralising antibodies, though one researcher cautioned that antibodies plus lenacapavir amount to suppression rather than a cure, according to the International AIDS Society.

links2

more episodes

All episodes